Patents by Inventor David A. Fink
David A. Fink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7750201Abstract: A wound dressing includes one or more layers containing a first anti-microbial agent and at least one of: a chelating agent, and a second anti-microbial agent.Type: GrantFiled: April 11, 2007Date of Patent: July 6, 2010Assignee: Tyco Healthcare Group LPInventors: Harish A. Patel, Hansen P. Swaniker, David G. Heagle, Kate Ward, Alain Tranchemontagne, E. David Fink, Ronald F. Vitaris, Chirag B. Shah, Sharon A. Mulligan, Brian Dowd, Scott Orr
-
Patent number: 7699823Abstract: A wound dressing apparatus includes a wound dressing member dimensioned for positioning relative to a wound bed. The wound dressing member including an internal vacuum reservoir and has a port in communication with the vacuum reservoir for applying subatmospheric pressure to the vacuum reservoir to facilitate removal of fluid from the wound bed. The wound dressing member includes a visual pressure indicator associated therewith for indicating a level of pressure within the vacuum reservoir. The visual pressure indicator includes color indicia having a plurality of colors corresponding to a condition of the pressure within the vacuum reservoir. The wound dressing member includes a lower absorbent member positionable adjacent the wound bed and an upper member which at least partially defines the vacuum reservoir. At least one of the top member and the lower absorbent member has the visual pressure indicator mounted thereto. The preferred visual pressure indicator includes an electronic position sensor.Type: GrantFiled: September 6, 2006Date of Patent: April 20, 2010Assignee: Tyco Healthcare Group LPInventors: Kurt Haggstrom, David Fink, Katja Grundmeier
-
Publication number: 20100081996Abstract: A securement device for securing a catheter to a patient is provided. The securement device includes a base including a support member and at least one securement arm extending away from the support member. The support member defines a cradle portion, the cradle portion of the support member being configured to receive at least a portion of a catheter. The at least one securement arm being movable over the cradle portion to a position to secure a catheter within the cradle portion. The securement device further includes a cover member configured to be received over the base and dimensioned to secure the base to a patient.Type: ApplicationFiled: September 29, 2009Publication date: April 1, 2010Applicant: Tyco Healthcare Group LPInventors: E. David Fink, Richard L. Fiser, Bradley M. Anthony, Billy Brandon, David Hibbitt
-
Publication number: 20100055437Abstract: An antimicrobial fiber is described including: an inner layer and an outer layer; wherein the inner layer and the outer layer comprise at least one of the following characteristics: (I) the inner layer and the outer layer comprise of different concentrations, or different release rates, of at least one antimicrobial agent; and (II) the inner layer and the outer layer comprise different antimicrobial agents. An alternative antimicrobial fiber includes an antimicrobial agent compounded or combined with a dissolvable substance to promote release or binding of the antimicrobial agent. Related articles are also described.Type: ApplicationFiled: August 27, 2009Publication date: March 4, 2010Applicant: Tyco Healthcare Group LPInventors: E. David Fink, Ronald F. Vitaris, Chirag B. Shah, Sharon A. Mulligan, Brian Dowd, Scott Orr
-
Publication number: 20100055142Abstract: A method of treating a substrate having a charge bias with at least one antimicrobial agent to modify the release properties of the antimicrobial agent with respect to the substrate, the method includes eliminating, mitigating, or modifying the charge bias of the substrate by applying at least one first agent to the substrate, and applying the at least one antimicrobial agent to the substrate. Related articles are also described.Type: ApplicationFiled: August 27, 2009Publication date: March 4, 2010Applicant: Tyco Healthcare Group LPInventors: David G. Heagle, Chirag B. Shah, Ronald F. Vitaris, E. David Fink, Sharon A. Mulligan, Brian Dowd
-
Publication number: 20100055158Abstract: An article includes a film layer; at least one layer of adhesive on at least one side of the film layer; a patch or strip comprising at least one antimicrobial agent, the patch or strip disposed on the same side of the film layer as the at least one layer of adhesive; and a relatively non-flexible sheet releasably attached to the side of the film layer opposite to the patch or strip.Type: ApplicationFiled: August 28, 2009Publication date: March 4, 2010Applicant: Tyco Healthcare Group LPInventors: Ronald F. Vitaris, Harish A. Patel, E. David Fink, Sharon A. Mulligan, Brian Dowd, Scott Orr, Chirag B. Shah
-
Publication number: 20090247509Abstract: The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders.Type: ApplicationFiled: April 17, 2009Publication date: October 1, 2009Applicant: AVENTIS PHARMACEUTICALS INC.Inventors: James A. Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski, Kenneth J. Bordeau, John G. Jurcak, Thaddeus R. Nieduzak, Sharon A. Jackson, Paul Angell, James P. Carey, George Lee, David Fink, Jean-Francois Sabuco, Yulin Chiang, Nicola Collar
-
Publication number: 20090199231Abstract: Methods and apparatus for managing, implementing and using interactive applications and content that are digitally recorded and viewed in real-time and/or a time-shifted moded are provided. The interactive applications may be associated with television programs or may be unrelated thereto, and may be transmitted together with television programs or separately therefrom. Interactive applications that are employed in a time-shifted mode can be matched to current conditions and interactive content may be updated to include current data. Users may view and manipulate highlights of television programs and receive alerts of occurrence of real-time events during viewing of recorded material. Additional manipulations of interactive applications and content are also enabled. Related apparatus and methods are also described.Type: ApplicationFiled: February 23, 2009Publication date: August 6, 2009Applicant: NDS LimitedInventors: Yossi Tsuria, Stephanie Wald, Gadi Tirosh, Ezra Darshan, David Richardson, David Fink, Moshe Shlissel, Menachem Vinokurov, Reuven Wachtfogel, Eli Jacobs, Einat Cohen, Ian Bastable
-
Patent number: 7521445Abstract: The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders.Type: GrantFiled: March 5, 2007Date of Patent: April 21, 2009Assignee: Aventis Pharmaceuticals Inc.Inventors: James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M Shutske, Joseph T Strupczewski, Kenneth J Bordeau, John G Jurcak, Thaddeus Nieduzak, Sharon A. Jackson, Paul Angell, James P Carey, George Lee, David Fink, Jean-Francois Sabuco, Yulin Chiang, Nicola Collar
-
Publication number: 20080273858Abstract: A method for producing an auxiliary video stream arranged for reverse trick mode playback from a video stream including a plurality of uni-directional predicted frames, the method including producing the auxiliary video stream by performing the following steps copying each uni-directional predicted frame included in the video stream into a memory, thereby producing a plurality of copied frames in the memory, replacing each one of the plurality of copied frames with one corresponding supplemental frame, thereby producing a plurality of corresponding supplemental frames, and producing a copy of the video stream arranged in reverse processing order, the producing a copy including replacing each frame which corresponds to one of the plurality of copied frames with the one corresponding supplemental frame from among the plurality of corresponding supplemental frames. Related methods and systems are also described.Type: ApplicationFiled: June 29, 2006Publication date: November 6, 2008Applicant: NDS LimitedInventors: Stephanie Wald, Ezra Darshan, David Fink, Kevin Murray
-
Publication number: 20080082059Abstract: A portable system for subatmospheric pressure therapy in connection with healing a surgical wound, includes a wound dressing dimensioned for positioning relative to a wound bed of a subject, a portable subatmospheric pressure mechanism dimensioned to be carried or worn by the subject and a container for collecting exudates from the wound bed removed under the subatmospheric pressure supplied by the subatmospheric pressure mechanism. The portable subatmospheric pressure mechanism includes a housing, a subatmospheric pressure source disposed within the housing and in fluid communication with the wound dressing to supply subatmospheric pressure to the wound dressing and a power source mounted to or within the housing for supplying power to actuate the subatmospheric pressure source.Type: ApplicationFiled: September 27, 2007Publication date: April 3, 2008Inventors: David Fink, David Heagle, Sharon Mulligan
-
Publication number: 20080044161Abstract: A method for switching from playing a first compressed data segment to playing a second compressed recorded data segment, the method including playing an uncompressed copy of a start of the second compressed recorded data segment upon switching from playing the first compressed data segment, decoding the second compressed recorded data segment from a preceding random access point, the preceding random access point preceding, in the second compressed recorded data segment, a point at which playing is to be switched to the second compressed recorded data segment, stopping the decoding of the second compressed recorded data segment when reaching a point beyond a point currently being played in the uncompressed copy, and switching to playing the second compressed recorded data segment when playing the uncompressed copy of a start of the second compressed recorded data segment reaches the point at which the decoding of the second compressed recorded data segment was stopped.Type: ApplicationFiled: June 8, 2005Publication date: February 21, 2008Applicant: NDS LimitedInventors: David White, Kevin Murray, Ezra Darshan, Moshe Shlissel, David Fink, David Whittaker, Zeev Geyzel, Reuven Wachtfogel
-
Publication number: 20070299112Abstract: The present invention discloses and claims compounds of formula (I) and formula (II), as inhibitors of human casein kinase I? and methods for using said compounds for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) or formula (II) and a method for the preparation of compounds of formula (I) or formula (II) are also disclosed and claimed.Type: ApplicationFiled: February 13, 2007Publication date: December 27, 2007Applicant: AVENTIS PHARMACEUTICAL INC.Inventors: David Fink, Yulin Chiang, Nicola Collar
-
Publication number: 20070265309Abstract: The present invention relates to a series of substituted bis aryl and heteroaryl compounds of formula (I): Wherein X, Y, Z, A, B, D, Ar, R1 and R2 are as defined herein. The compounds of this invention are selective 5HT2A antagonists, and are therefore, useful in treating a variety of diseases including but not limited to a wide variety of sleep disorders as disclosed and claimed herein.Type: ApplicationFiled: July 25, 2007Publication date: November 15, 2007Applicant: AVENTIS PHARMACEUTICALS INC.Inventors: Paul EASTWOOD, Hazel HUNT, David FINK, Helen SMITH, Richard TODD
-
Publication number: 20070219516Abstract: An x-ray detectable element for use in association with a surgical absorbent substrate includes a detectable element having an extruded sheath at least partially encasing an elongated radiopaque core. The absorbent substrate may include, woven and non-woven, surgical sponges and gauze.Type: ApplicationFiled: March 6, 2007Publication date: September 20, 2007Inventors: Harish Patel, David Fink
-
Publication number: 20070207124Abstract: The invention provides a vector, preferably a herpes simplex virus (HSV) vector, comprising a polynucleotide sequence encoding a glutamic acid decarboxylase (GAD) protein. The invention also provides a stock of such vectors and a pharmaceutical composition comprising such vectors. The invention further provides a method of treating pain, such as spinal cord injury pain, in a mammal comprising administering to a mammal a vector comprising a nucleotide sequence encoding a glutamic acid decarboxylase (GAD) protein in an amount effective to treat spinal cord injury pain.Type: ApplicationFiled: October 28, 2005Publication date: September 6, 2007Applicants: University of Pittsburgh of the Commonwealth System of Higher Education, Department of Veterans Affairs (024)Inventors: Joseph Glorioso, David Fink, Darren Wolfe, David Krisky
-
Publication number: 20070161641Abstract: The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates is to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders.Type: ApplicationFiled: March 5, 2007Publication date: July 12, 2007Applicant: Aventis Pharmaceuticals Inc.Inventors: James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory Shutske, Joseph Strupczewski, Kenneth Bordeau, John Jurcak, Thaddeus Nieduzak, Sharon Jackson, Paul Angell, James Carey, George Lee, David Fink, Jean-Francois Sabuco, Yulin Chiang, Nicola Collar
-
Publication number: 20070066946Abstract: A wound dressing apparatus includes a wound dressing member dimensioned for positioning relative to a wound bed. The wound dressing member including an internal vacuum reservoir and has a port in communication with the vacuum reservoir for applying subatmospheric pressure to the vacuum reservoir to facilitate removal of fluid from the wound bed. The wound dressing member includes a visual pressure indicator associated therewith for indicating a level of pressure within the vacuum reservoir. The visual pressure indicator includes color indicia having a plurality of colors corresponding to a condition of the pressure within the vacuum reservoir. The wound dressing member includes a lower absorbent member positionable adjacent the wound bed and an upper member which at least partially defines the vacuum reservoir. At least one of the top member and the lower absorbent member has the visual pressure indicator mounted thereto. The preferred visual pressure indicator includes an electronic position sensor.Type: ApplicationFiled: September 6, 2006Publication date: March 22, 2007Inventors: Kurt Haggstrom, David Fink, Katja Grundmeier
-
Patent number: 7186724Abstract: The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders.Type: GrantFiled: April 6, 2004Date of Patent: March 6, 2007Assignee: Aventis Pharmaceuticals Inc.Inventors: James A Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M Shutske, Jospeh T Strupczewski, Kenneth J Bordeau, John G Jurcak, Thaddeus Nieduzak, Sharon A Jackson, Paul Angell, James P Carey, George Lee, David Fink, Jean-Fancois Sabuco, Yulin Chiang, Nicola Collar
-
Patent number: D539056Type: GrantFiled: May 10, 2006Date of Patent: March 27, 2007Assignee: National Inventor's Hall of Fame FoundationInventors: Keith Helmetag, David Fink, Mitch Scott, Laurie Mobley